UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3692) 3692
Newsletter (17) 17
Book Chapter (11) 11
Newspaper Article (7) 7
Publication (4) 4
Dissertation (1) 1
Magazine Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2168) 2168
male (2042) 2042
science & technology (1934) 1934
life sciences & biomedicine (1898) 1898
animals (1714) 1714
female (1491) 1491
biological and medical sciences (1458) 1458
medical sciences (1233) 1233
epoprostenol - administration & dosage (1180) 1180
adult (878) 878
epoprostenol - pharmacology (876) 876
epoprostenol - therapeutic use (848) 848
middle aged (817) 817
rats (768) 768
hypertension, pulmonary - drug therapy (741) 741
pharmacology. drug treatments (734) 734
prostacyclin (720) 720
epoprostenol - analogs & derivatives (656) 656
abridged index medicus (647) 647
cardiovascular system & cardiology (512) 512
epoprostenol - biosynthesis (506) 506
pulmonary hypertension (495) 495
antihypertensive agents - administration & dosage (428) 428
pharmacology & pharmacy (427) 427
aged (426) 426
dose-response relationship, drug (423) 423
epoprostenol - metabolism (414) 414
blood pressure - drug effects (407) 407
cardiac & cardiovascular systems (392) 392
epoprostenol (361) 361
respiratory system (358) 358
platelet aggregation - drug effects (355) 355
cardiovascular system (348) 348
antihypertensive agents - therapeutic use (322) 322
infusions, intravenous (320) 320
treatment outcome (306) 306
hypertension, pulmonary - physiopathology (303) 303
general & internal medicine (299) 299
hemodynamics - drug effects (290) 290
time factors (285) 285
dogs (271) 271
administration, inhalation (267) 267
fundamental and applied biological sciences. psychology (252) 252
epoprostenol - adverse effects (248) 248
administration, oral (247) 247
in vitro techniques (242) 242
nitric oxide (238) 238
rabbits (237) 237
indomethacin - pharmacology (222) 222
epoprostenol - blood (220) 220
hypertension (220) 220
vasodilator agents - therapeutic use (217) 217
rats, inbred strains (216) 216
vasodilator agents - administration & dosage (213) 213
peripheral vascular disease (205) 205
pulmonary arterial hypertension (190) 190
critical care medicine (189) 189
vascular resistance - drug effects (185) 185
drug therapy, combination (184) 184
drug therapy (183) 183
mice (178) 178
adolescent (174) 174
cardiology. vascular system (172) 172
care and treatment (169) 169
rats, sprague-dawley (164) 164
epoprostenol - physiology (163) 163
prostaglandins (163) 163
hypertension, pulmonary - etiology (162) 162
blood platelets - drug effects (161) 161
aspirin - pharmacology (160) 160
surgery (160) 160
iloprost (159) 159
vasodilation - drug effects (157) 157
treprostinil (154) 154
pneumology (151) 151
blood. blood coagulation. reticuloendothelial system (150) 150
rats, wistar (148) 148
heart rate - drug effects (145) 145
double-blind method (144) 144
prostaglandins - pharmacology (142) 142
disease models, animal (141) 141
research (141) 141
platelet aggregation inhibitors - pharmacology (140) 140
vasodilator agents - pharmacology (139) 139
pulmonary hypertension. acute cor pulmonale. pulmonary embolism. pulmonary vascular diseases (137) 137
antihypertensive agents - adverse effects (136) 136
physiology (134) 134
aspirin - administration & dosage (132) 132
6-ketoprostaglandin f1 alpha - blood (130) 130
injections, intravenous (129) 129
endothelium (128) 128
cells, cultured (127) 127
pregnancy (124) 124
thromboxane b2 - blood (124) 124
endothelium, vascular - drug effects (123) 123
biochemistry & molecular biology (120) 120
prospective studies (117) 117
arachidonic acid (116) 116
follow-up studies (115) 115
child (113) 113
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3545) 3545
Japanese (101) 101
German (44) 44
French (29) 29
Russian (21) 21
Spanish (20) 20
Chinese (18) 18
Polish (17) 17
Italian (15) 15
Serbian (3) 3
Slovak (3) 3
Czech (2) 2
Danish (2) 2
Hungarian (2) 2
Norwegian (2) 2
Portuguese (2) 2
Turkish (2) 2
Dutch (1) 1
Lithuanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of internal medicine, ISSN 0003-4819, 10/2008, Volume 149, Issue 8, pp. 521 - 530
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 12/2017, Volume 363, Issue 3, pp. 348 - 357
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Nanoparticles - chemistry | Vasodilator Agents - pharmacokinetics | Phosphatidylethanolamines - adverse effects | Humans | Excipients - adverse effects | Male | Polyethylene Glycols - chemistry | Squalene - analogs & derivatives | Drug Compounding | Hypertension, Pulmonary - drug therapy | Epoprostenol - pharmacokinetics | Guinea Pigs | Squalene - adverse effects | Antihypertensive Agents - therapeutic use | Excipients - administration & dosage | Rats, Sprague-Dawley | Epoprostenol - analogs & derivatives | Lung - drug effects | Vasodilation - drug effects | Phosphatidylethanolamines - chemistry | Drug Delivery Systems - adverse effects | Epoprostenol - administration & dosage | Prodrugs - administration & dosage | Epoprostenol - metabolism | Vasodilator Agents - therapeutic use | Antihypertensive Agents - administration & dosage | Polyethylene Glycols - adverse effects | Hypertension, Pulmonary - blood | Nanoparticles - adverse effects | Dose-Response Relationship, Drug | Epoprostenol - therapeutic use | Excipients - chemistry | Epoprostenol - pharmacology | Female | Lung - metabolism | Platelet Aggregation - drug effects | Drug Evaluation, Preclinical | Squalene - chemistry | Vasodilator Agents - pharmacology | Administration, Inhalation | Phosphatidylethanolamines - administration & dosage | Squalene - administration & dosage | Antihypertensive Agents - pharmacokinetics | Polyethylene Glycols - administration & dosage | Animals | Prodrugs - pharmacokinetics | Dogs | Nanoparticles - administration & dosage | Prodrugs - therapeutic use | Lung - blood supply | Prodrugs - pharmacology | Vasodilator Agents - administration & dosage | Index Medicus
Journal Article
Journal Article
Chest, ISSN 0012-3692, 06/2009, Volume 135, Issue 6, pp. 1455 - 1461
Prostacyclin | Bosentan | Sildenafil | Sarcoidosis | Pulmonary hypertension | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Pneumology | Piperazines - administration & dosage | Sarcoidosis - mortality | Follow-Up Studies | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Purines - administration & dosage | Hemodynamics - physiology | Sildenafil Citrate | Statistics, Nonparametric | Female | Hypertension, Pulmonary - drug therapy | Retrospective Studies | Drug Therapy, Combination | Severity of Illness Index | Hypertension, Pulmonary - mortality | Sarcoidosis - diagnosis | Iloprost - administration & dosage | Risk Assessment | Administration, Oral | Kaplan-Meier Estimate | Administration, Inhalation | Probability | Linear Models | Survival Rate | Treatment Outcome | Sarcoidosis - complications | Aged | Hemodynamics - drug effects | Respiratory Function Tests | Hypertension, Pulmonary - etiology | Sulfonamides - administration & dosage | Cohort Studies | Epoprostenol - administration & dosage | Sulfones - administration & dosage | Index Medicus | Abridged Index Medicus | sarcoidosis | Original Research | bosentan | prostacyclin | sildenafil | pulmonary hypertension
Journal Article
Journal of controlled release, ISSN 0168-3659, 01/2015, Volume 197, pp. 97 - 104
Encapsulation | Biodegradable nanoparticle | Pulmonary arterial hypertension | Beraprost sodium | Prostaglandin I | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Polymers - administration & dosage | Rhodamines - administration & dosage | Nanoparticles - chemistry | Rats, Wistar | Monocrotaline | Capillary Permeability - drug effects | Drug Carriers - administration & dosage | Delayed-Action Preparations - chemistry | Male | Polyethylene Glycols - chemistry | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Pulmonary Artery - metabolism | Delayed-Action Preparations - pharmacokinetics | Polyesters | Hypertension, Pulmonary - drug therapy | Rhodamines - chemistry | Lactic Acid - administration & dosage | Disease Models, Animal | Epoprostenol - pharmacokinetics | Lactic Acid - chemistry | Mice, Inbred C57BL | Hypertension, Pulmonary - metabolism | Pulmonary Artery - drug effects | Polyethylene Glycols - administration & dosage | Epoprostenol - analogs & derivatives | Animals | Epoprostenol - chemistry | Polymers - chemistry | Drug Carriers - pharmacokinetics | Nanoparticles - administration & dosage | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Epoprostenol - administration & dosage | Nanoparticles | Fluorescence | Models | Analysis | Pulmonary hypertension | Drugs | Drug delivery systems | Drug discovery | Vehicles | Index Medicus
Journal Article
Journal Article